Navigation Links
CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound
Date:7/1/2008

INDIANAPOLIS, July 1 /PRNewswire/ -- CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced it closed a $25 million Series B financing. New investor Care Capital led the round, which included previous investors Pappas Ventures, Domain Associates, Pearl Street Venture Funds and Triathlon Medical Ventures. The financing will be used to further develop a unique migraine compound, COL-144, and to advance a preclinical pipeline of novel chemical entities targeting neurological and psychiatric disorders.

COL-144 is a first-in-class Neurally Acting Anti-Migraine Agent (NAAMA) designed to deliver efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapy. COL-144 selectively targets 5HT1F receptors expressed in the trigeminal nerve pathway. CoLucid completed a Phase II clinical trial last year examining the efficacy of COL-144 in the acute treatment of migraine after intravenous administration. The trial provided clear evidence of safe, effective alleviation of migraine pain and identified a range of doses that provided relief of migraine symptoms and were well tolerated. Based on these encouraging results, CoLucid is advancing clinical development of COL-144 as a treatment for migraine by the oral route of administration.

As a part of the Series B financing, CoLucid also announced the addition of Richard Markham, partner at Care Capital, to the Board of Directors. Prior to joining Care Capital, Markham held several senior leadership positions in the pharmaceutical industry, including CEO of Aventis Pharma, CEO of Hoechst Marion Roussel and President, COO and Board member of Marion Merrell Dow. In addition, he served as President and COO of Merck.

"COL-144 is the first in a new class of migraine therapeutics and represents a paradigm shift in the treatment of migraine," said James White, Ph.D., President and CE
'/>"/>

SOURCE CoLucid Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... (May 24, 2013) The news about youth and diabetes ... diabetes study shows that children who develop Type 2 diabetes ... problems faster and at a higher rate than people who ... kids have Type 2 diabetes, they seem to be at ... said Jane Lynch, M.D., professor of pediatric endocrinology in the ...
(Date:5/24/2013)... 2013 Fit Yummy Mummy, a fitness ... who are trying to get rid of the belly ... ideal for women who want to combine exercises with ... ’s Stan Stevenson, prompting an investigative review. , “Holly's ... a wide variety of motivational strategies, nutritional plans, proper ...
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... nutrition school, is happy to announce that it has donated ... that supports the women held captive in Cleveland, Ohio. , ... Gina de Jesus, Michelle Knight, and Amanda Berry and her ... captive for a decade, we were shocked and horrified,” said ...
(Date:5/24/2013)... May 24, 2013 General Data ... barcode identification, tracking and data management products and ... Biomedical Sciences Inc., (TBS) of Durham, North Carolina, ... and consumables for the clinical and research pathology ... Data Healthcare, which provides specialty products and solutions ...
(Date:5/24/2013)... help schizophrenics? Finding the answer for this is at the ... Researchers from the Bergen fMRI Group at the University of ... hear voices. The way they do this is by studying ... from a mental illness. For a five-year period, the group ... A recent report published in Frontiers in Human Neuroscience ...
Breaking Medicine News(10 mins):Health News:Youth with type 2 diabetes at much higher risk for heart, kidney disease 2Health News:Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released 2Health News:Integrative Nutrition Donates $10,000 to the Cleveland Courage Fund 2Health News:General Data Acquires Triangle Biomedical Sciences 2Health News:General Data Acquires Triangle Biomedical Sciences 3Health News:Help at hand for schizophrenics 2
... By Denise Mann HealthDay Reporter , MONDAY, Jan. ... high-volume hospitals may fare better than those who are treated ... but this is not due to volume alone. New ... spot and handle complications should they occur after heart surgery. ...
... faces are everywhere. Whether it,s New Hampshire,s erstwhile granite "Old ... our brains are adept at locating images that look like ... into thinking such objects actually are human faces. "You ... on the other hand, you,re not misled into believing that ...
... 2011 The pathology of Parkinson,s disease is characterized by ... the substantia nigra (SN), an area of the brain associated ... protein in the form of Lewy bodies (LB) in the ... thought to progress along with the clinical course of Parkinson,s ...
... agents have a demonstrated efficacy in children with Attention-deficit/hyperactivity ... single pharmacologic agent. A recent study by Dr. Timothy ... issue of the Journal of the American Academy ... first randomized placebo-controlled trial designed to assess efficacy and ...
... Center researchers identified a new culprit that leads to ... into plaque and narrows arteries. The research, published online ... explains why cholesterol-laden, coronary artery disease-causing cells called macrophages, ... macrophages that accumulate in plaques secrete a molecule called ...
... (HealthDay News) -- Most parents who have genetic tests for ... new study finds. Researchers interviewed 253 parents who underwent ... (BRCA1 and BRCA2) that can be inherited. All the participants ... the genetic test. Twenty-nine percent of the parents were ...
Cached Medicine News:Health News:Kids Who Need Heart Surgery May Fare Better at Busier Hospitals 2Health News:MIT: How does our brain know what is a face and what's not? 2Health News:MIT: How does our brain know what is a face and what's not? 3Health News:New study supports view that Lewy bodies are not the primary cause of cell death in PD 2Health News:Combination therapy shows positive response for children with ADHD 2Health News:Researchers discover new culprit in atherosclerosis 2Health News:Most Parents Tell Kids About Test Results for Breast Cancer Genes 2
(Date:5/24/2013)... , May 24, 2013 /PRNewswire-iReach/ -- Phoenix Houses ... non-profit substance abuse services organization, is hosting its tenth ... Hills Hotel on June 6, 2013.  More than 300 ... funds for the adolescent residential treatment centers, family therapy, ... honor individuals whose accomplishments have positive influences on the ...
(Date:5/24/2013)... Solta Medical, Inc. (NASDAQ: SLTM ), a global ... Edward W. Knowlton has resigned as a ... Knowlton is the founder of Thermage, the predecessor company to ... "On behalf of the entire Board of Directors, ... thank Ed for his tireless dedication to our company and ...
(Date:5/24/2013)... 24, 2013  An international roster of experts on ... in Santa Monica, Calif. , to ... for MPM, a rare form of cancer that results ... the lining of the chest. Hosted by ... the 3rd Annual International Symposium on Lung-Sparing Therapies for ...
Breaking Medicine Technology:Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3
... 21 /PRNewswire/ Terumo Heart, Inc. today,announced the discharge of ... Assist System (LVAS). The patient was,discharged home on August ... after receiving the device., The patient is a ... heart failure for nearly 20 years. He is the ...
... have a study,that is falling behind with recruitment? Have ... media but still have not seen the,desired results? Perhaps ... to help,your sites navigate the world of media placements ... Argonauta Assist(TM) service," says Ms. Ann Kottcamp,President of Argonauta ...
Cached Medicine Technology:Discharge of First U.S. DuraHeart(TM) Patient 2Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts 2
... Protection System helps protect infants, patients, staff, ... operating efficiencies, cost savings, and overall peace ... and constrained healthcare facilities., And with HALO, ... and versatile solution, but also unique-skin sensing ...
... enables immediate infant location ... door locking and abduction ... match infants to their ... switching, secure their safety ...
The AeroScout Exciter extends the AeroScout system to provide robust and sophisticated RFID detection capabilities....
... medicine is the ability of medical equipment, ... ways based on what is happening around ... a Radianse indoor positioning solution (IPS) establishes ... requires identity, location and time to be ...
Medicine Products: